Article taken from: http://www.healthcentral.com

Author:CRegal

As many likely already are aware, Gilenya was approved by the FDA for use in the United States back in September 2010.  It is the first–and only–oral disease-modifying drug for multiple sclerosis.  Once thought to be something that would only exist in a futuristic world with flying cars and jet packs, an oral MS drug is a reality.

Unfortunately, it may also carry serious side effects. More >